Effects of Trimethoxystilbene on Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells

Cell Biochemistry and Biophysics

Volumn 64, Issue 2, 2012, Pages 101-106

  Gao, Ge ^a   Wang, Xin ^b   Qin, Xiaoqun ^a   Jiang, Xinyu ^c   Xiang, Daxiong ^b   Xie, Li ^b   Hu, Jianguo ^b   Gao, Jiesheng ^b  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Apoptosis; Pulmonary artery smooth muscles cells; Pulmonary hypertension; Resveratrol; Trimethoxystilbene

Indexed keywords

3,4',5 TRIMETHOXYSTILBENE; 3,4',5-TRIMETHOXYSTILBENE; ANTIINFLAMMATORY AGENT; RESVERATROL; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HYPERTENSION; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; PULMONARY ARTERY; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MYOCYTES, SMOOTH MUSCLE; PULMONARY ARTERY; RATS; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867747893     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-012-9377-7     Document Type: Article

References (28)

1. Vegh, J., Szodoray, P., Kappelmayer, J., Csipo, I., Udvardy, M., Lakos, G., et al. (2006). Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension. Scandinavian Journal of Immunology, 64, 69-76.
2. Abolmaali, N., Seitz, U., Esmaeili, A., Kock, M., Radeloff, D., Ackermann, H., et al. (2007). Evaluation of a resistance-based model for the quantification of pulmonary arterial hypertension using MR flow measurements. Journal of Magnetic Resonance Imaging, 26, 646-653.
3. Farber, H. W., & Loscalzo, J. (2004). Pulmonary arterial hypertension. New England Journal of Medicine, 351, 1655-1665.
4. Humbert, M., Sitbon, O., & Simonneau, G. (2004). Treatment of pulmonary arterial hypertension. New England Journal of Medicine, 351, 1425-1436.
5. Ma, N., Liu, W. Y., Li, H. D., et al. (2007). Reverse-phase HPLC study of resveratrol derivative (BTM-0512) in rat plasma and distribution in tissue. Yao Xue Xue Bao, 42, 1183-1188.
6. Godichaud, S., Si-Tayeb, K., Auge, N., Desmouliere, A., Balabaud, C., Payrastre, B., et al. (2006). The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. International Journal of Biochemistry & Cell Biology, 38, 629-637.
7. Kopp, P. (1998). Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? European Journal of Endocrinology, 138, 619-620.
8. Bertelli, A. A., Giovannini, L., Stradi, R., Urien, S., Tillement, J. P., & Bertelli, A. (1996). Kinetics of trans- and cis-resveratrol (3, 4′, 5-trihydroxystilbene) after red wine oral administration in rats. International Journal of Clinical Pharmacology Research, 16, 77-81.
9. Kaneko, T., Tahara, S., & Takabayashi, F. (2003). Suppression of lipid hydroperoxide-induced oxidative damage to cellular DNA by esculetin. Biological & Pharmaceutical Bulletin, 26, 840-844.
10. Virag, L., Szabo, E., Gergely, P., & Szabo, C. (2003). Peroxynitrite-induced cytotoxicity: Mechanism and opportunities for intervention. Toxicology Letters, 140-141, 113-124.
11. Cai, Y. J., Fang, J. G., Ma, L. P., Yang, L., & Liu, Z. L. (2003). Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochimica et Biophysica Acta, 1637, 31-38.
12. Yen, G. C., Duh, P. D., & Lin, C. W. (2003). Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radical Research, 37, 509-514.
13. Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., & Mukhtar, H. (2001). Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clinical Cancer Research, 7, 1466-1473.
14. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., & Lin, J. K. (2003). Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochemical Pharmacology, 65, 1053-1060.
15. Narayanan, B. A., Narayanan, N. K., Re, G. G., & Nixon, D. W. (2003). Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. International Journal of Cancer, 104, 204-212.
16. Holmes-McNary, M., & Baldwin, A. S, Jr. (2000). Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Research, 60, 3477-3483.
17. Afaq, F., Adhami, V. M., & Ahmad, N. (2003). Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicology and Applied Pharmacology, 186, 28-37.
18. Adhami, V. M., Afaq, F., & Ahmad, N. (2003). Suppression of ultraviolet B exposure-mediated activation of NF-kappaB in normal human keratinocytes by resveratrol. Neoplasia, 5, 74-82.
19. Pellegatta, F., Bertelli, A. A., Staels, B., Duhem, C., Fulgenzi, A., & Ferrero, M. E. (2003). Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells. American Journal of Clinical Nutrition, 77, 1220-1228.
20. Ashikawa, K., Majumdar, S., Banerjee, S., Bharti, A. C., Shishodia, S., & Aggarwal, B. B. (2002). Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation. Journal of Immunology, 169, 6490-6497.
21. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., et al. (1998). Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. Journal of Biological Chemistry, 273, 21875-21882.
22. Surh, Y. J., Chun, K. S., Cha, H. H., Han, S. S., Keum, Y. S., Park, K. K., et al. (2001). Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutation Research, 480-481, 243-268.
23. Wang, D. (2004). Study of methods to measure concentration of resveratrol in rat blood after a single intake with drinking water. Chinese Journal Clinical Pharmacology Therapeutics, 9, 646-649. Chinese.
24. Elmali, N., Esenkaya, I., Harma, A., Ertem, K., Turkoz, Y., & Mizrak, B. (2005). Effect of resveratrol in experimental osteoarthritis in rabbits. Inflammation Research, 54, 158-162.
25. Schneider, Y., Chabert, P., Stutzmann, J., Coelho, D., Fougerousse, A., Gosse, F., et al. (2003). Resveratrol analog (Z)-3, 5, 4′-trimethoxystilbene is a potent anti-mitotic drug inhibiting tubulin polymerization. International Journal of Cancer, 107, 189-196.
26. Xiang D, Gao J, Jiang X. Use of resveratrol in treatment of immune diseases. China. 200710034534. 6 [P]. 2008-09-17.
27. Mouria, M., Gukovskaya, A. S., Jung, Y., Buechler, P., Hines, O. J., Reber, H. A., et al. (2002). Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. International Journal of Cancer, 98, 761-769.
28. Ning, M., & Diaxong, X. (2009). Studies on metabolic structures and pathways of resveratrol derivative in rat urine. Chinese Journal Pharmaceutical Analysis, 29, 1994-2001.